June 09, 2022
Article
Combining radiotherapy with next-generation hormonal therapy is a feasible approach to explore in phase 3 trials enrolling patients with high-risk localized or locally advanced prostate cancer, according to an analysis of the phase 3 ATLAS trial.
December 02, 2021
Article
The study included patients who were Hispanic and from the south Florida region, which was not included in previous studies.
December 01, 2021
Article
Men who were obese and on active surveillance had worse urinary incontinence compared to non-obese peers through 5 years.
September 19, 2021
Article
Sabizabulin was well tolerated and associated with significant and durable objective tumor responses in patients with metastatic castration resistant prostate cancer.